Article · 31 Mar 2025
EditorialPublished 2016
Nuclear Medicine Imaging in Epilepsy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For epilepsy patients who are not responding to anticonvulsant medications, surgery is an alternative treatment. A key issue in epilepsy surgery is the accurate localization of the “epileptogenic zone”. To date, pre-surgical evaluation of the epileptogenic network can be carried out by Electroencephalogram (EEG), video-EEG, magnetic resonance imaging, magneto-encephalography, single-photon emission computed tomography (SPECT) and positron emission tomography (PET). The interictal FDG-PET reveals hypometaboism at the epileptic focus, and it has been demonstrated to be much more sensitive than the interictal SPECT, and similarly sensitive to the ictal SPECT for the accurate localization of epileptogenic foci prior to surgical therapy. Visual assessment of 18F-FDG-PET is associated with interobserver and intraobserver variability. We have studied the issues of rigorous quantitation of FDG-PET brain studies and developed self-normalization technique. In addition to FDG-PET imaging, PET receptor imaging has also been demonstrated to provide significant insight into the mechanisms of neurotransmitters in epileptogenesis. In conclusion, we believe that nuclear medicine imaging can facilitate the identification of epileptic foci and investigate novel treatment for epilepsy.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 18 Oct 2022
Epilepsy Diagnosis using Digital Transformation and Learning from Raw Images
Conference abstract · 2022
The correlation between cluster seizures and findings of magnetic resonance imaging in drug refractory epilepsy patients
Conference abstract · 3 Sep 2021
The Electroactive Signal for the Tau Peptide- Part 2: Neuromolecular Imaging (NMI): A LIVE Nanotechnology for Alzheimer, Parkinson and Epilepsy Disease: The BRODERICK PROBE� Biosensor Images the Effects of the Pharmaceutical, L-DOPA, in Long-Term Neurodegeneration in Parkinson Subjects
Short communication · Apr 2021
The Electroactive Signal for the Tau Peptide: Neuromolecular Imaging (NMI): A LIVE Nanotechnology for Alzheimer, Parkinson and Epilepsy Disease
More from this journal
The newest in Epilepsy Journal.
Article · 15 Feb 2026
Factors Associated with Seizure Attacks in Epileptic Patients at Felege Hiwot Referral Hospital: Application of Linear Mixed Model
Brief report · 29 Dec 2025
Neuroimaging: Key Biomarkers for Brain Disorders
Brief report · 29 Dec 2025
AI-Powered Neuroimaging Biomarkers: Advancing Brain Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEpilepsy Journal
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Jiaqiong Wang”
- BylineArticles whose byline prints “Robert Carroll”

